Edwards’ Peripheral Artery Growth-Factor Data Pooled By NIH’s Lederman
This article was originally published in The Pink Sheet Daily
Executive Summary
Intermittent claudication endpoint in Edwards/Sangamo gene-therapy compound study promoted by National Heart, Lung & Blood Institute principal investigator Lederman at Transcatheter Cardiovascular Therapeutics conference.